FDANonrulemakingFDA-2025-D-5107
Who commented on this docket
Menstrual Products - Labeling and Performance Testing Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
1 organizations filed 1 public comment on Menstrual Products - Labeling and Performance Testing Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 193d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 193d ago
Abstract
Open
Commenters (1)
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.